| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.035 | 0.2 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |